Nicolas Turmel1, Pierre Lévy2, Claire Hentzen3, Camille Chesnel3, Audrey Charlanes3, Samer Sheikh-Ismael3, Gérard Amarenco3, Philippe Manceau3. 1. GREEN GRC 01 UPMC Sorbonne Universite, Hôpital Tenon, Service de Neuro-Urologie, 4 Rue de la Chine, 75020, Paris, France. nicolasturmel@yahoo.fr. 2. Departement de Sante Publique Et Unité de Neurophysiologie Clinique Hopital Tenon (APHP), UPMC and Inserm UMR S 1136 (EPAR Team) 4, Rue de la Chine, 75970, Paris Cedex 20, France. 3. GREEN GRC 01 UPMC Sorbonne Universite, Hôpital Tenon, Service de Neuro-Urologie, 4 Rue de la Chine, 75020, Paris, France.
Abstract
OBJECTIVES: To develop a new tool to assess constraints due to urinary treatments in neurological patients. MATERIALS AND METHODS: A prospective, monocentric study has been conducted from January to May 2017. Out-patients (multiple sclerosis, spinal cord injury, Parkinson disease) were included in a referral center if they had LUTS treatment for at least 3 months. To validate psychometric properties, we conducted a literature review, qualitative interviews, and discussion with a panel of six experts. Comprehension, acceptation, and pertinence were tested by a pilot study. A validation study, designed to calculate content validity, internal consistency reliability, and test-retest reliability [intraclass correlation coefficient (ICC)] has been conducted. The primary outcome was good psychometric properties defined with Cronbach's α > 0.7 and ICC > 0.7. RESULTS: Comprehension, acceptation, and pertinence were excellent. Validation study showed a perfect content validity (r2 = 1) and excellent internal consistency reliability (Cronbach' α = 0.90). Total score was between 0 (best score) to 66 (maximal constraints). Test-retest reliability calculated using ICC was 0.81. Time to fill questionnaire was 4 min 20 s. The final version was composed by 22 items. CONCLUSION: LUTS TCA is the first validated tool to assess constraints of urinary treatment and has excellent psychometric properties.
OBJECTIVES: To develop a new tool to assess constraints due to urinary treatments in neurological patients. MATERIALS AND METHODS: A prospective, monocentric study has been conducted from January to May 2017. Out-patients (multiple sclerosis, spinal cord injury, Parkinson disease) were included in a referral center if they had LUTS treatment for at least 3 months. To validate psychometric properties, we conducted a literature review, qualitative interviews, and discussion with a panel of six experts. Comprehension, acceptation, and pertinence were tested by a pilot study. A validation study, designed to calculate content validity, internal consistency reliability, and test-retest reliability [intraclass correlation coefficient (ICC)] has been conducted. The primary outcome was good psychometric properties defined with Cronbach's α > 0.7 and ICC > 0.7. RESULTS: Comprehension, acceptation, and pertinence were excellent. Validation study showed a perfect content validity (r2 = 1) and excellent internal consistency reliability (Cronbach' α = 0.90). Total score was between 0 (best score) to 66 (maximal constraints). Test-retest reliability calculated using ICC was 0.81. Time to fill questionnaire was 4 min 20 s. The final version was composed by 22 items. CONCLUSION: LUTS TCA is the first validated tool to assess constraints of urinary treatment and has excellent psychometric properties.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein Journal: Urology Date: 2003-01 Impact factor: 2.649
Authors: Karin S Coyne; Marion Kvasz; Andrea M Ireland; Ian Milsom; Zoe S Kopp; Chris R Chapple Journal: Eur Urol Date: 2011-07-26 Impact factor: 20.096
Authors: Miguel A Ruiz; Antonio Pardo; Javier Rejas; Javier Soto; Fernando Villasante; José L Aranguren Journal: Value Health Date: 2008-05-20 Impact factor: 5.725
Authors: Mark J Atkinson; Anusha Sinha; Steven L Hass; Shoshana S Colman; Ritesh N Kumar; Meryl Brod; Clayton R Rowland Journal: Health Qual Life Outcomes Date: 2004-02-26 Impact factor: 3.186